Tumor marker pyruvate kinase type tumor M2 in patients suffering from diabetic nephropathyOREMEK, G. M; RUTNER, F; SAPOUTZIS, N et al.Anticancer research. 2003, Vol 23, Num 2A, pp 1155-1158, issn 0250-7005, 4 p.Conference Paper

Pre-analytical problems in the measurement of tumor type pyruvate kinase (tumor M2-PK)OREMEK, G. M; GERSTMEIER, F; SAUER-EPPEL, H et al.Anticancer research. 2003, Vol 23, Num 2A, pp 1127-1130, issn 0250-7005, 4 p.Conference Paper

Chronic endothelin receptor blockade prevents both early hyperfiltration and late overt diabetic nephropathy in the ratDING, Shuang-Shuang; CHANGBIN QIU; HESS, Patrick et al.Journal of cardiovascular pharmacology. 2003, Vol 42, Num 1, pp 48-54, issn 0160-2446, 7 p.Article

ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathyGROSS, M.-L; EL-SHAKMAK, A; SZABO, A et al.Diabetologia (Berlin). 2003, Vol 46, Num 6, pp 856-868, issn 0012-186X, 13 p.Article

Tamm-Horsfall protein in Balkan endemic nephropathyDUBRAVKA CVORISCEC; STAVLJENIC, A; RADONIC, M et al.Journal of clinical chemistry and clinical biochemistry. 1985, Vol 23, Num 4, pp 177-181, issn 0340-076XArticle

E-selectin-inducing activity in plasma from type 2 diabetic patients with maculopathyKNUDSEN, S. T; FOSS, C. H; POULSEN, P. L et al.American journal of physiology. Endocrinology and metabolism. 2003, Vol 47, Num 1, pp 1-6, issn 0193-1849, 6 p.Article

What is the impact of PRIME on real-life diabetic nephropathy?RUILOPE, L. M.International journal of clinical practice (Esher). 2004, Vol 58, Num 3, pp 268-276, issn 1368-5031, 9 p.Article

Glutamine:fructose-6-phosphate aminotransferase enzyme activity is necessary for the induction of TGF-β1 and fibronectin expression in mesangial cellsWEIGERT, C; FRIESS, U; BRODBECK, K et al.Diabetologia (Berlin). 2003, Vol 46, Num 6, pp 852-855, issn 0012-186X, 4 p.Article

Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathyMOON, Pyong-Gon; LEE, Jeong-Eun; KIM, Yong-Lim et al.Proteomics (Weinheim. Print). 2011, Vol 11, Num 12, pp 2459-2475, issn 1615-9853, 17 p.Article

Young scholars award lecture : Intratubular angiotensinogen in hypertension and kidney diseasesKOBORI, Hiroyuki; OZAWA, Yuri; SUZAKI, Yuki et al.American journal of hypertension. 2006, Vol 19, Num 5, pp 541-550, issn 0895-7061, 10 p.Article

Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathyNAGAI, Kojiro; MATSUBARA, Takeshi; KITA, Toru et al.Kidney international. 2005, Vol 68, Num 2, pp 552-561, issn 0085-2538, 10 p.Article

Association between polymorphisms of the Atrial Natriuretic Peptide gene and proteinuria: a population-based studyNANNIPIERI, M; POSADAS, R; WILLIAMS, K et al.Diabetologia (Berlin). 2003, Vol 46, Num 3, pp 429-432, issn 0012-186X, 4 p.Article

Effect of acute hyperglycaemia on selected plasma and urinary cytokine antagonists in Type 1 diabetes mellitusPELIKANOVA, T; SIMKOVA, R; TESAR, V et al.Diabetologia (Berlin). 2003, Vol 46, Num 4, pp 470-474, issn 0012-186X, 5 p.Article

Homocysteine as a risk factor for nephropathy and retinopathy in Type 2 diabetesLOOKER, H. C; FAGOT-CAMPAGNA, A; GUNTER, E. W et al.Diabetologia (Berlin). 2003, Vol 46, Num 6, pp 766-772, issn 0012-186X, 7 p.Article

Metabolic activation of carcinogenic aristolochic acid, a risk factor for Balkan endemic nephropathySTIBOROVA, Marie; FREI, Eva; ARLT, Volker M et al.Mutation research. Reviews in mutation research. 2008, Vol 658, Num 1-2, pp 55-67, issn 1383-5742, 13 p.Article

Renoprotective effects of vasopeptidase inhibition in an experimental model of diabetic nephropathyDAVIS, B. J; JOHNSTON, C. I; BURRELL, L. M et al.Diabetologia (Berlin). 2003, Vol 46, Num 7, pp 961-971, issn 0012-186X, 11 p.Article

Role of macromolecular IgA in IgA nephropathyVAN DER BOOG, Paul J. M; VAN KOOTEN, Cees; DE FIJTER, Johan W et al.Kidney international. 2005, Vol 67, Num 3, pp 813-821, issn 0085-2538, 9 p.Article

Familial factors in diabetic nephropathy : an offspring studyAGIUS, E; ATTARD, G; SHAKESPEARE, L et al.Diabetic medicine. 2006, Vol 23, Num 3, pp 331-334, issn 0742-3071, 4 p.Article

Highly elevated serum phyto-oestrogen concentrations in patients with diabetic nephropathyVON HERTZEN, L; FORSBLOM, C; STUMPF, K et al.Journal of internal medicine. 2004, Vol 255, Num 5, pp 602-609, issn 0954-6820, 8 p.Article

Therapeutic effect of recombinant human erythropoietin on anaemia with erythropoietin deficiency in diabetic patientsKIM, D. J; KIM, Y. M; LEE, H. C et al.Diabetic medicine. 2003, Vol 20, Num 8, pp 661-664, issn 0742-3071, 4 p.Article

Enhanced urinary adiponectin excretion in IgA-nephropathy patients with proteinuriaSHIMOTOMAI, Takashi; KAKEI, Masafumi; NARITA, Takuma et al.Renal failure. 2005, Vol 27, Num 3, pp 323-328, issn 0886-022X, 6 p.Article

Preventive effect of cerivastatin on diabetic nephropathy through suppression of glomerular macrophage recruitment in a rat modelOTA, T; TAKAMURA, T; ANDO, H et al.Diabetologia (Berlin). 2003, Vol 46, Num 6, pp 843-851, issn 0012-186X, 9 p.Article

Incidence and geographic distribution of serologically verified cases of nephropathia epidemica in SwedenSETTERGREN, B; JUTO, P; WADELL, G et al.American journal of epidemiology. 1988, Vol 127, Num 4, pp 801-807, issn 0002-9262Article

In situ protein Kinase C activity is increased in cultured fibroblasts from Type 1 diabetic patients with nephropathyIORI, E; MARESCOTTI, M. C; VEDOVATO, M et al.Diabetologia (Berlin). 2003, Vol 46, Num 4, pp 524-530, issn 0012-186X, 7 p.Article

Cytogenetic studies in Balkan endemic nephropathyTONCHEVA, D; DIMITROV, T; TZONEVA, M et al.Nephron. 1988, Vol 48, Num 1, pp 18-21, issn 0028-2766Article